These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 17432437)

  • 21. [Treatment of neoplastic diseases with TEM].
    MIKHAILOV V; ANDREEV B; NAIDENOV V; MARKOV M
    Suvr Med (Sofiia); 1958; 9(4):42-8. PubMed ID: 13603215
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeting breast cancer stem cells.
    Wicha MS
    Breast; 2009 Oct; 18 Suppl 3():S56-8. PubMed ID: 19914544
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA approves new drug for specific type of advanced breast cancer.
    Mayo Clin Womens Healthsource; 2007 Oct; 11(10):3. PubMed ID: 18418907
    [No Abstract]   [Full Text] [Related]  

  • 24. Lapatinib study supports cancer stem cell hypothesis, encourages industry research.
    Schmidt C
    J Natl Cancer Inst; 2008 May; 100(10):694-5. PubMed ID: 18477795
    [No Abstract]   [Full Text] [Related]  

  • 25. Biological therapy of breast cancer: recent clinical applications.
    Baar J
    Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Position statement of the (Hungarian) College of Oncology and Radiotherapy regarding the financing of Tyverb (lapatinib) based on individual discretionary compassionate care].
    Pikó B;
    Magy Onkol; 2009 Mar; 53(1):77-9. PubMed ID: 19318330
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute paronychia caused by lapatinib therapy.
    Rigopoulos D; Gregoriou S; Belyayeva Y; Larios G; Gkouvi A; Katsambas A
    Clin Exp Dermatol; 2009 Jan; 34(1):94-5. PubMed ID: 19076807
    [No Abstract]   [Full Text] [Related]  

  • 28. Closing in on a cure.
    Healy B
    US News World Rep; 2006 Oct; 141(15):67. PubMed ID: 17432437
    [No Abstract]   [Full Text] [Related]  

  • 29. Lapatinib-associated toxicity and practical management recommendations.
    Moy B; Goss PE
    Oncologist; 2007 Jul; 12(7):756-65. PubMed ID: 17673607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired resistance to small molecule ErbB2 tyrosine kinase inhibitors.
    Chen FL; Xia W; Spector NL
    Clin Cancer Res; 2008 Nov; 14(21):6730-4. PubMed ID: 18980964
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.